Cargando…

Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study

[Image: see text] Background: In this study, we developed a novel risk score named the blood routine test parameters (BRTP) score to predict the clinical outcomes in coronary artery disease (CAD) patients who had undergone percutaneous coronary intervention (PCI). Methods: There were 6049 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Zheng, Ying-Ying, Wu, Ting-Ting, Ma, Xiang, Ma, Yi-Tong, Xie, Xiang, Tang, Bao-Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655762/
https://www.ncbi.nlm.nih.gov/pubmed/34901600
http://dx.doi.org/10.1021/acsomega.1c03990
_version_ 1784612139031330816
author Zhang, Jian
Zheng, Ying-Ying
Wu, Ting-Ting
Ma, Xiang
Ma, Yi-Tong
Xie, Xiang
Tang, Bao-Peng
author_facet Zhang, Jian
Zheng, Ying-Ying
Wu, Ting-Ting
Ma, Xiang
Ma, Yi-Tong
Xie, Xiang
Tang, Bao-Peng
author_sort Zhang, Jian
collection PubMed
description [Image: see text] Background: In this study, we developed a novel risk score named the blood routine test parameters (BRTP) score to predict the clinical outcomes in coronary artery disease (CAD) patients who had undergone percutaneous coronary intervention (PCI). Methods: There were 6049 patients with CAD after PCI enrolled in CORFCHD-PCI from January 2008 to December 2016. We divided these patients into two groups according to diabetes (diabetic group, n = 3809, and nondiabetic group, n = 2240). During a follow-up time of 35.9 ± 22.6 months, we compared the incidences of all-cause mortality (ACM) and cardiac mortality (CM), which were assigned as the primary outcomes between patients with a high BRTP score (≥5 points) and those with a low BRTP score (<5 points). Results: We found that the BRTP score independently predicted the risk for ACM and CM in both diabetic patients [ACM, hazard risk (HR) = 1.748 (95% confidence interval (CI): 1.186–2.575), P = 0.005; CM, HR = 1.728 (95% CI: 1.120–2.667), P = 0.014] and nondiabetic patients [ACM, HR = 1.682 (95% CI: 1.208–2.340), P = 0.002; CM, HR = 1.718 (95% CI: 1.188–2.484), P = 0.004]. However, the BRTP score was found to be an independent predictor for major adverse cardiovascular event (MACE) and major adverse cardiovascular and cerebrovascular event (MACCE) in diabetic patients [MACE, HR = 1.366 (95% CI: 1.076–1.734), P = 0.010; MACCE, HR = 1.330 (95% CI: 1.035–1.710), P = 0.026] but not in nondiabetic patients [MACE, HR = 1.241 (95% CI: 0.994–1.549), P = 0.056; MACCE, HR = 1.238 (95% CI: 0.981–1.562), P = 0.072]. Conclusions: This study suggests that the BRTP score is an independent and novel predictor of mortality in CAD patients who had undergone PCI, especially in patients with comorbidity of diabetes. Trial registration: ChiCTR-ROC-16010153. Registered 14, December, 2016.
format Online
Article
Text
id pubmed-8655762
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-86557622021-12-10 Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study Zhang, Jian Zheng, Ying-Ying Wu, Ting-Ting Ma, Xiang Ma, Yi-Tong Xie, Xiang Tang, Bao-Peng ACS Omega [Image: see text] Background: In this study, we developed a novel risk score named the blood routine test parameters (BRTP) score to predict the clinical outcomes in coronary artery disease (CAD) patients who had undergone percutaneous coronary intervention (PCI). Methods: There were 6049 patients with CAD after PCI enrolled in CORFCHD-PCI from January 2008 to December 2016. We divided these patients into two groups according to diabetes (diabetic group, n = 3809, and nondiabetic group, n = 2240). During a follow-up time of 35.9 ± 22.6 months, we compared the incidences of all-cause mortality (ACM) and cardiac mortality (CM), which were assigned as the primary outcomes between patients with a high BRTP score (≥5 points) and those with a low BRTP score (<5 points). Results: We found that the BRTP score independently predicted the risk for ACM and CM in both diabetic patients [ACM, hazard risk (HR) = 1.748 (95% confidence interval (CI): 1.186–2.575), P = 0.005; CM, HR = 1.728 (95% CI: 1.120–2.667), P = 0.014] and nondiabetic patients [ACM, HR = 1.682 (95% CI: 1.208–2.340), P = 0.002; CM, HR = 1.718 (95% CI: 1.188–2.484), P = 0.004]. However, the BRTP score was found to be an independent predictor for major adverse cardiovascular event (MACE) and major adverse cardiovascular and cerebrovascular event (MACCE) in diabetic patients [MACE, HR = 1.366 (95% CI: 1.076–1.734), P = 0.010; MACCE, HR = 1.330 (95% CI: 1.035–1.710), P = 0.026] but not in nondiabetic patients [MACE, HR = 1.241 (95% CI: 0.994–1.549), P = 0.056; MACCE, HR = 1.238 (95% CI: 0.981–1.562), P = 0.072]. Conclusions: This study suggests that the BRTP score is an independent and novel predictor of mortality in CAD patients who had undergone PCI, especially in patients with comorbidity of diabetes. Trial registration: ChiCTR-ROC-16010153. Registered 14, December, 2016. American Chemical Society 2021-11-29 /pmc/articles/PMC8655762/ /pubmed/34901600 http://dx.doi.org/10.1021/acsomega.1c03990 Text en © 2021 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Zhang, Jian
Zheng, Ying-Ying
Wu, Ting-Ting
Ma, Xiang
Ma, Yi-Tong
Xie, Xiang
Tang, Bao-Peng
Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study
title Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study
title_full Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study
title_fullStr Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study
title_full_unstemmed Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study
title_short Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study
title_sort blood routine test parameters score, a novel predictor of adverse outcomes of coronary artery disease patients with or without diabetes who underwent percutaneous coronary intervention: a retrospective cohort study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655762/
https://www.ncbi.nlm.nih.gov/pubmed/34901600
http://dx.doi.org/10.1021/acsomega.1c03990
work_keys_str_mv AT zhangjian bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy
AT zhengyingying bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy
AT wutingting bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy
AT maxiang bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy
AT mayitong bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy
AT xiexiang bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy
AT tangbaopeng bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy